Clinical trials
Renal Insufficiency trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 10 |
| Unknown status | 7 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akebia Therapeutics | 4 |
| Novartis Pharmaceuticals | 4 |
| Abbott Medical Devices | 2 |
| Guerbet | 2 |
| Mario Negri Institute for Pharmacological Research | 2 |
| University of Roma La Sapienza | 2 |
| Advanz Pharma | 1 |
| Ascelia Pharma AB | 1 |
| AstraZeneca | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 51 |
| Renal Insufficiency, Chronic | 10 |
| Anemia | 7 |
| Kidney Diseases | 5 |
| Heart Failure | 4 |
| Hypertension | 4 |
| Kidney Failure, Chronic | 4 |
| Cardiovascular Diseases | 3 |
| Coronary Artery Disease | 3 |
| Renal Artery Obstruction | 3 |
Trials
Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.